Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS - Savona, M. R., Pollyea, D. A., Stock, W., Oehler, V. G., Schroeder, M. A., Lancet, J., McCloskey, J., Kantarjian, H. M., Ma, W. W., Shaik, M. N., Laird, A. D., Zeremski, M., O'Connell, A., Chan, G., Cortes, J. E. (The American Association for Cancer Research (AACR), 2018)
6258908